These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 4004829
1. Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues. Ostermann G, Kertscher HP, Till U. Biomed Biochim Acta; 1985; 44(2):K17-23. PubMed ID: 4004829 [Abstract] [Full Text] [Related]
2. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro. Ostermann G, Hofmann B, Kertscher HP, Till U. J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804 [Abstract] [Full Text] [Related]
3. Effect of synthetic phospholipids on platelet aggregation and serotonin release. Söling U, Eibl H, Nagel GA, Unger C. Lipids; 1987 Nov; 22(11):868-70. PubMed ID: 3444380 [Abstract] [Full Text] [Related]
4. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages. Herrmann DB, Ferber E, Munder PG. Biochim Biophys Acta; 1986 Mar 21; 876(1):28-35. PubMed ID: 3947667 [Abstract] [Full Text] [Related]
5. Halo lipids. VI. Stimulation of human and rabbit blood platelets by racemic halo analogues of O-alkyl-glycerophosphocholine. Ostermann G, Brachwitz H, Till U. Biomed Biochim Acta; 1984 Mar 21; 43(3):349-55. PubMed ID: 6743307 [Abstract] [Full Text] [Related]
6. Stimulation and desensitization of human and rabbit platelets by 1-O-hexadecyl-2-O-methyl-rac-glycero-3-phosphocholine and analogues. Ostermann G, Kertscher HP, Lang A, Till U. Thromb Res; 1986 Sep 15; 43(6):675-80. PubMed ID: 3764811 [No Abstract] [Full Text] [Related]
7. Synthesis and biochemical studies of analogs of platelet-activating factor bearing a methyl group at C2 of the glycerol backbone. Bittman R, Witzke NM, Lee TC, Blank ML, Snyder F. J Lipid Res; 1987 Jun 15; 28(6):733-8. PubMed ID: 3611974 [Abstract] [Full Text] [Related]
8. Proaggregatory and inhibitory effects of 2-O-ethyl analogues of platelet-activating factor (PAF) on human and rabbit platelets. Hofmann B, Ostermann G, Kertscher HP, Till U. Thromb Res; 1988 Feb 15; 49(4):415-23. PubMed ID: 3381200 [Abstract] [Full Text] [Related]
9. Effects of synthetic analogues of platelet-activating factor (PAF) on fibrinolytic activity in the rat. Hofmann B, Meisgeier U, Kertscher P, Ostermann G. Biomed Biochim Acta; 1988 Feb 15; 47(10-11):S161-4. PubMed ID: 3150268 [Abstract] [Full Text] [Related]
10. The enantiomer and the positional isomer of platelet-activating factor. Tence M, Coëffier E, Polonsky J, Benveniste J. Biochim Biophys Acta; 1983 Feb 22; 755(3):526-30. PubMed ID: 6824744 [Abstract] [Full Text] [Related]
11. Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets. Ostermann G, Till U, Thielmann K. Thromb Res; 1984 Feb 15; 33(4):409-18. PubMed ID: 6710440 [Abstract] [Full Text] [Related]
12. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives. Keraly CL, Benveniste J. Br J Haematol; 1982 Jun 15; 51(2):313-22. PubMed ID: 7082588 [Abstract] [Full Text] [Related]
13. Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation. Kulikov VI, Muzya GI. Biochemistry (Mosc); 2000 Apr 15; 65(4):427-30. PubMed ID: 10810178 [Abstract] [Full Text] [Related]
14. PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine)-induced fibrinogen binding to platelets depends on metabolic energy. Kloprogge E, Hasselaar P, Akkerman JW. Biochem J; 1986 Sep 15; 238(3):885-91. PubMed ID: 3800968 [Abstract] [Full Text] [Related]
15. Effect of structural analogues of PAF-acether on platelet desensitization. Keraly CL, Coëffier E, Tencé M, Borrel MC, Benveniste J. Br J Haematol; 1983 Mar 15; 53(3):513-21. PubMed ID: 6824590 [Abstract] [Full Text] [Related]
16. [Effect of sn-2-acetylated analogs of phosphatidalic acid on release and aggregation of human platelets]. Muzia GI, Kulikov VI. Biokhimiia; 1996 Mar 15; 61(3):455-60. PubMed ID: 8724603 [Abstract] [Full Text] [Related]
17. Biochemical characterization of the interaction of lipid phosphoric acids with human platelets: comparison with platelet activating factor. Sugiura T, Tokumura A, Gregory L, Nouchi T, Weintraub ST, Hanahan DJ. Arch Biochem Biophys; 1994 Jun 15; 311(2):358-68. PubMed ID: 8203898 [Abstract] [Full Text] [Related]
18. [Characteristics of the activation of rabbit platelets induced by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activation factor)]. Kozlov VK, Filatova LV, Kulikov VI, Markosian RA, Bergel'son LD. Biull Eksp Biol Med; 1985 Oct 15; 100(10):410-2. PubMed ID: 4052603 [Abstract] [Full Text] [Related]
19. The effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glycero-3-phosphocholine and its analogues platelet activating factor and carbamyl-platelet activating factor on the biosynthesis of interleukin-6 in human thymic epithelial cells cultivated in vitro. Cardile V, Mascarucci P, De Simoni MG, Jiang X, Bindoni M. Cytokine; 1996 Sep 15; 8(9):698-701. PubMed ID: 8932980 [Abstract] [Full Text] [Related]
20. 1-O-hexadecyl-2-acetyl-sn-3-glycerophosphorylcholine (PAF): some effects on the aggregation of human platelets by thrombin or collagen. Hornby EJ, Perry CR. Thromb Haemost; 1983 Aug 30; 50(2):586-7. PubMed ID: 6636035 [Abstract] [Full Text] [Related] Page: [Next] [New Search]